Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,153 | 993 | 597 | 249 | 140 |
| Gross Profit | 1,153 | 993 | 597 | 249 | 140 |
| Operating Expenses | 11,969 | 14,993 | 10,563 | 10,414 | 7,739 |
| Operating Income | -10,816 | -14,000 | -9,966 | -10,165 | -7,599 |
| Other Income | 172 | 132 | 122 | 402 | 1,188 |
| Pre-tax Income | -10,644 | -13,868 | -9,844 | -9,763 | -6,411 |
| Net Income Continuous | -10,644 | -13,868 | -9,844 | -9,763 | -6,411 |
| Minority Interests | N/A | -6 | -8 | -594 | -535 |
| Net Income | $-10,644 | $-13,862 | $-9,836 | $-9,169 | $-5,876 |
| EPS Basic Total Ops | -0.74 | 76.01 | -36.02 | -36.21 | -21.60 |
| EPS Basic Continuous Ops | -0.74 | 62.53 | -29.36 | -29.16 | -19.42 |
| EPS Diluted Total Ops | -0.74 | 76.01 | -36.02 | -36.21 | -21.60 |
| EPS Diluted Continuous Ops | -0.74 | 62.53 | -29.36 | -29.16 | -19.42 |
| EBITDA(a) | $-10,721 | $-13,901 | $-9,872 | $-10,082 | $-7,512 |